Nevin SAĞSÖZ, Murat BULANIK, Sabri KURTAY, Yüksel IŞIK

DOĞUM EYLEMİNDE PERİNEAL-İNGUİNAL HERPES ZOSTER ENFEKSİYONU: Nadir bir olgu sunumu

Amaç: Herpes Zoster (zona) enfeksiyonu yaşam boyu görülme sıklığı % 0,3-0,8 olan, varisella zoster virusunun (VZV) primer olarak nöral dokuyu tuttuğu fakat komplikasyonları dermatolojik, nörolojik, oftalmolojik ya da visseral olabilen viral enfeksiyondur Gebelikte varisella zoster enfeksiyonu 1-5/10.000 gibi düşük insidansa sahipken olgulardaki VZV seropozitifliği oldukça yüksektir (> % 95). Gebelikte bulaş in-utero, perinatal, postnatal olabilir. Mortalitesi yüksek olan neonatal suçiçeği enfeksiyonu ise doğum sırasındaki bulaş sonucu ortaya çıkar. Bu yazıda gebeliğinde travay takibinde zona enfeksiyonu geçiren ve bunun üzerine sezeryan ile doğumu gerçekleştirilen bir olgu sunularak konu literatur bilgileri eşliğinde tartışıldı.

Perineal-Inguinal Herpes Zoster Infection in Labor: A Rare Case Report

Aim: Herpes zoster (shingles), is a viral infection, with the life time incidence between % 0.30.8, that can primarily effect the neural tissue but which has dermatological, neurological, ophtalmological or visceral complications, caused by varicella zoster virus (VZV)As VZV infection has low incidence as 1-5/10.000 and the patients have significantly high seropositivity (>%95). Transmission in pregnancy can occur in utero, perinatally or postnatally. Neonatal chickenpox infection, on the other hand, is transmitted during labor which has high mortality rates. In this report, a case which had HZ infection during labor and and thus gone to caeserian section with a live birth has been presented and this topic have been discussed by the literature knowledge.

PDF

___

1. Gnann JW Jr, Whitley R. Clinical practice. Herpes zoster. N Engl J Med. 2002; 347(5):340-6.
2. Dumas AM, Geelen JL, Mares W, Van Der Noordaa J. Infectivity and molecular weight of varicella-zoster virus DNA. J Gen Virol. 1980; 47(1):233-5.
3. Müllegger RR, Häring NS, Glatz M. Skin infections in pregnancy. Clin Dermatol. 2016; 34(3):368-77.
4. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology. 1995; 45 (12 Suppl 8): S41-6.
5. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M.Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994; 343 (8912):1548-51.
6. Heininger U, Seward JF. Varicella. Lancet. 2006; 368(9544):1365-76.
7. Koren G. Congenital varicella syndrome in the third trimester. Lancet. 2005; 366 (9497):1591-2.
8 Smith CK, Arvin AM. Varicella in the fetus and newborn. Semin Fetal Neonatal Med. 2009;14(4):209-17.
9. Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;22;56(RR-4):1-40.